Search Browse Earnings

Arcutis Biotherapeutics, Inc. — SlamSEC

Arcutis Biotherapeutics, Inc.

Nasdaq:ARQT

Pharmaceutical Preparations·WESTLAKE VILLAGE, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$59.6M

+1517.1% YoY

FY 2025

Adj. EBITDA

-$240.3M

-403.1% margin

FY 2025

Net Income

-$262.1M

-439.8% margin

FY 2025

EPS (Diluted)

-$3.78

FY 2025

Stock Price

$23.95

-2.6%

2026-03-11

52W Range

$11.86 – $31.77

P/E Ratio

-6.3x

Market Cap

$3.0B

Cash

$71.3M

FY 2025

Total Debt

$107.2M

FY 2025

Net Debt

$35.9M

FY 2025

Enterprise Value

$3.0B

Debt / EBITDA

-0.1x

FY 2025

EV / EBITDA

-12.5x

Employees

—

CFO

Vairavan Latha